Rockwell Medical (RMTI) Share-based Compensation Growth (3y) (2013 - 2026)
Rockwell Medical (RMTI) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | 10.06% |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | 9.14% |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 0.43% |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | -8.13% |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | -1.73% |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | -8.04% |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | - |
| 10 | Rockwell Medical | 29.77 Mn | 4.98 Mn | 3.24 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35.39% |
| Jun 30, 2025 | 118.08% |
| Dec 31, 2024 | -58.26% |
| Sep 30, 2024 | 6.41% |
| Jun 30, 2024 | 44.19% |
| Mar 31, 2024 | 102.92% |
| Mar 31, 2023 | -27.24% |
| Dec 31, 2022 | -40.74% |
| Sep 30, 2022 | -56.16% |
| Jun 30, 2022 | -59.87% |
| Dec 31, 2021 | -41.89% |
| Sep 30, 2021 | -16.25% |
| Jun 30, 2021 | -31.81% |
| Mar 31, 2021 | -36.25% |
| Mar 31, 2020 | -39.47% |
| Dec 31, 2019 | -25.45% |
| Sep 30, 2019 | -6.53% |
| Jun 30, 2019 | -16.11% |
| Dec 31, 2018 | 60.97% |
| Sep 30, 2018 | -17.71% |